Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults

[1] Andersen K(1999)Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group Neurol 53 1992-7

[2] Launer LJ(2002)Incidence of AD may decline in the early 90s for men, later for women: The Cache County study Neurology 58 209-18

[3] Dewey ME(2002)Dementia and Alzheimer disease incidence: a prospective cohort study Arch Neurol 59 1737-46

[4] Letenneur L(2015)Gender and incidence of dementia in the Framingham Heart Study from mid-adult life Alzheimers Dement 11 310-20

[5] Ott A(1997)Estrogen, cognition, and a woman's risk of Alzheimer's disease Am J Med 103 11S-8S

[6] Copeland JR(2002)Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study JAMA 288 2123-9

[7] Dartigues JF(2007)CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study Neurology 69 631-9

[8] Kragh-Sorensen P(2007)Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults Arch Neurol 64 343-9

[9] Baldereschi M(2006)Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans Ann Neurol 59 512-9

[10] Brayne C(2015)Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study JAMA Neurol 72 316-24

[1] Andersen K(1999)Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group Neurol 53 1992-7

[2] Launer LJ(2002)Incidence of AD may decline in the early 90s for men, later for women: The Cache County study Neurology 58 209-18

[3] Dewey ME(2002)Dementia and Alzheimer disease incidence: a prospective cohort study Arch Neurol 59 1737-46

[4] Letenneur L(2015)Gender and incidence of dementia in the Framingham Heart Study from mid-adult life Alzheimers Dement 11 310-20

[5] Ott A(1997)Estrogen, cognition, and a woman's risk of Alzheimer's disease Am J Med 103 11S-8S

[6] Copeland JR(2002)Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study JAMA 288 2123-9

[7] Dartigues JF(2007)CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study Neurology 69 631-9

[8] Kragh-Sorensen P(2007)Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults Arch Neurol 64 343-9

[9] Baldereschi M(2006)Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans Ann Neurol 59 512-9

[10] Brayne C(2015)Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study JAMA Neurol 72 316-24